Status:
COMPLETED
Evaluation of EUS-guided FNA for Diagnosing Autoimmune Pancreatitis
Lead Sponsor:
Bin Cheng
Conditions:
Autoimmune Pancreatitis
Eligibility:
All Genders
20-85 years
Phase:
NA
Brief Summary
The aim is to evaluate EUS-FNA efficacy for AIP diagnosis using a 22-gauge (G) needle.
Detailed Description
Patients who suggested having Autoimmune pancreatitis (AIP) and underwent endoscopic ultrasound-guided fine needle aspiration (EUS-FNA） by using a standard 22-gauge aspiration needle were enrolled bet...
Eligibility Criteria
Inclusion
- age \>20 years old, \<85 years old ; probable AIP.
Exclusion
- steroid administration within 3 months before the initiation of treatment; refusal or inability to provide informed consent; acute pancreatitis in previous 2 weeks; cardiorespiratory dysfunction; mental diseases; coagulopathy; drug addiction(asprin, clopidogrel).
Key Trial Info
Start Date :
January 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2017
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT03241797
Start Date
January 1 2013
End Date
May 1 2017
Last Update
August 8 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tongji hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China, 430030